BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reddy SK, Marsh JW, Varley PR, Mock BK, Chopra KB, Geller DA, Tsung A. Underlying steatohepatitis, but not simple hepatic steatosis, increases morbidity after liver resection: a case-control study. Hepatology. 2012;56:2221-2230. [PMID: 22767263 DOI: 10.1002/hep.25935] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 6.4] [Reference Citation Analysis]
Number Citing Articles
1 Tian Y, Lyu H, He Y, Xia Y, Li J, Shen F. Comparison of Hepatectomy for Patients with Metabolic Syndrome-Related HCC and HBV-Related HCC. J Gastrointest Surg 2018;22:615-23. [PMID: 29139083 DOI: 10.1007/s11605-017-3629-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
2 Hobeika C, Cauchy F, Sartoris R, Beaufrère A, Yoh T, Vilgrain V, Rautou PE, Paradis V, Bouattour M, Ronot M, Soubrane O. Relevance of liver surface nodularity for preoperative risk assessment in patients with resectable hepatocellular carcinoma. Br J Surg 2020;107:878-88. [PMID: 32118298 DOI: 10.1002/bjs.11511] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
3 Zhao J, van Mierlo KMC, Gómez-Ramírez J, Kim H, Pilgrim CHC, Pessaux P, Rensen SS, van der Stok EP, Schaap FG, Soubrane O, Takamoto T, Viganò L, Winkens B, Dejong CHC, Olde Damink SWM; Chemotherapy-Associated Liver Injury (CALI) consortium. Systematic review of the influence of chemotherapy-associated liver injury on outcome after partial hepatectomy for colorectal liver metastases. Br J Surg 2017;104:990-1002. [PMID: 28542731 DOI: 10.1002/bjs.10572] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 11.8] [Reference Citation Analysis]
4 Zaky HS, Gad AM, Nemr E, Hassan W, Abd El-Raouf OM, Ali AA. Modulatory effects of some natural products on hepatotoxicity induced by combination of sodium valproate and paracetamol in rats. J Biochem Mol Toxicol 2018;:e22162. [PMID: 29799656 DOI: 10.1002/jbt.22162] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
5 Yano K, Nanashima A, Fujii Y, Hiyoshi M, Imamura N, Hamada T, Tsuchimochi Y, Wada T, Mizutani Y, Hirai T. Preoperative regional maximal removal rate of technetium-99m-galactosyl human serum albumin is correlated with liver functional parameters, but did not predict postoperative morbidity. Nucl Med Commun 2017;38:701-7. [PMID: 28644197 DOI: 10.1097/MNM.0000000000000702] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
6 Viganò L, Conci S, Cescon M, Fava C, Capelli P, D'Errico A, Torzilli G, Di Tommaso L, Giuliante F, Vecchio FM, Salizzoni M, David E, Pinna AD, Guglielmi A, Capussotti L. Liver resection for hepatocellular carcinoma in patients with metabolic syndrome: A multicenter matched analysis with HCV-related HCC. J Hepatol 2015;63:93-101. [PMID: 25646890 DOI: 10.1016/j.jhep.2015.01.024] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 8.0] [Reference Citation Analysis]
7 Casper M, Zimmermann S, Weber SN, Arslanow A, Lammert F, Krawczyk M. Risk of chemotherapy-associated liver injury (CALI) in PNPLA3 p.148M allele carriers: Preliminary results of a transient elastography-based study. Digestive and Liver Disease 2020;52:102-6. [DOI: 10.1016/j.dld.2019.09.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Jin C, Kumar P, Gracia‐sancho J, Dufour J. Calcium transfer between endoplasmic reticulum and mitochondria in liver diseases. FEBS Lett 2021;595:1411-21. [DOI: 10.1002/1873-3468.14078] [Reference Citation Analysis]
9 Jacobsen MC, Thrower SL, Ger RB, Leng S, Court LE, Brock KK, Tamm EP, Cressman ENK, Cody DD, Layman RR. Multi-energy computed tomography and material quantification: Current barriers and opportunities for advancement. Med Phys 2020;47:3752-71. [PMID: 32453879 DOI: 10.1002/mp.14241] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Nomi T, Fuks D, Ferraz JM, Kawaguchi Y, Nakajima Y, Gayet B. Influence of body mass index on postoperative outcomes after laparoscopic liver resection. Surg Endosc 2015;29:3647-54. [PMID: 25737295 DOI: 10.1007/s00464-015-4121-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
11 Honmyo N, Kobayashi T, Kuroda S, Oshita A, Onoe T, Kohashi T, Fukuda S, Ohmori I, Abe T, Imaoka Y, Akita T, Tanaka J, Ohdan H. A novel model for predicting posthepatectomy liver failure based on liver function and degree of liver resection in patients with hepatocellular carcinoma. HPB 2021;23:134-43. [DOI: 10.1016/j.hpb.2020.05.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Tohme S, Goswami J, Han K, Chidi AP, Geller DA, Reddy S, Gleisner A, Tsung A. Minimally Invasive Resection of Colorectal Cancer Liver Metastases Leads to an Earlier Initiation of Chemotherapy Compared to Open Surgery. J Gastrointest Surg 2015;19:2199-206. [PMID: 26438480 DOI: 10.1007/s11605-015-2962-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 5.7] [Reference Citation Analysis]
13 Chaves Cayuela N, Kiyomi Koike M, Jacysyn JF, Rasslan R, Azevedo Cerqueira AR, Pereira Costa SK, Picanço Diniz-Júnior JA, Massazo Utiyama E, Frasson de Souza Montero E. N-Acetylcysteine Reduced Ischemia and Reperfusion Damage Associated with Steatohepatitis in Mice. Int J Mol Sci 2020;21:E4106. [PMID: 32526845 DOI: 10.3390/ijms21114106] [Reference Citation Analysis]
14 Lafaro K, Buettner S, Maqsood H, Wagner D, Bagante F, Spolverato G, Xu L, Kamel I, Pawlik TM. Defining Post Hepatectomy Liver Insufficiency: Where do We stand? J Gastrointest Surg. 2015;19:2079-2092. [PMID: 26063080 DOI: 10.1007/s11605-015-2872-6] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 10.0] [Reference Citation Analysis]
15 Reiniers MJ, van Golen RF, van Gulik TM, Heger M. Reactive oxygen and nitrogen species in steatotic hepatocytes: a molecular perspective on the pathophysiology of ischemia-reperfusion injury in the fatty liver. Antioxid Redox Signal. 2014;21:1119-1142. [PMID: 24294945 DOI: 10.1089/ars.2013.5486] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 8.4] [Reference Citation Analysis]
16 Mattar RE, Al-alem F, Simoneau E, Hassanain M. Preoperative selection of patients with colorectal cancer liver metastasis for hepatic resection. World J Gastroenterol 2016; 22(2): 567-581 [PMID: 26811608 DOI: 10.3748/wjg.v22.i2.567] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 20] [Article Influence: 5.4] [Reference Citation Analysis]
17 Ramos E, Torras J, Lladó L, Rafecas A, Serrano T, Lopez-Gordo S, Busquets J, Fabregat J. The influence of steatosis on the short- and long-term results of resection of liver metastases from colorectal carcinoma. HPB (Oxford) 2016;18:389-96. [PMID: 27037210 DOI: 10.1016/j.hpb.2015.12.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
18 Zhang J, Ren Y, Bi J, Wang M, Zhang L, Wang T, Wei S, Mou X, Lv Y, Wu R. Involvement of kindlin-2 in irisin's protection against ischaemia reperfusion-induced liver injury in high-fat diet-fed mice. J Cell Mol Med 2020;24:13081-92. [PMID: 32954626 DOI: 10.1111/jcmm.15910] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
19 Cauchy F, Belghiti J. A clinical perspective of the link between metabolic syndrome and hepatocellular carcinoma. J Hepatocell Carcinoma 2015;2:19-27. [PMID: 27508191 DOI: 10.2147/JHC.S44521] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Park GC, Song GW, Moon DB, Lee SG. A review of current status of living donor liver transplantation. Hepatobiliary Surg Nutr 2016;5:107-17. [PMID: 27115004 DOI: 10.3978/j.issn.2304-3881.2015.08.04] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
21 Cauchy F, Soubrane O, Belghiti J. Liver resection for HCC: patient's selection and controversial scenarios. Best Pract Res Clin Gastroenterol. 2014;28:881-896. [PMID: 25260315 DOI: 10.1016/j.bpg.2014.08.013] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
22 Song GW, Lee SG. Living donor liver transplantation. Curr Opin Organ Transplant. 2014;19:217-222. [PMID: 24807211 DOI: 10.1097/mot.0000000000000088] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
23 Hobeika C, Ronot M, Beaufrere A, Paradis V, Soubrane O, Cauchy F. Metabolic syndrome and hepatic surgery. J Visc Surg 2020;157:231-8. [PMID: 31866269 DOI: 10.1016/j.jviscsurg.2019.11.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Holterman A, Gurria J, Tanpure S, Disomma N. Nonalcoholic fatty liver disease and bariatric surgery in adolescents. Seminars in Pediatric Surgery 2014;23:49-57. [DOI: 10.1053/j.sempedsurg.2013.10.016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
25 Amptoulach S, Gross G, Kalaitzakis E. Differential impact of obesity and diabetes mellitus on survival after liver resection for colorectal cancer metastases. J Surg Res. 2015;199:378-385. [PMID: 26115811 DOI: 10.1016/j.jss.2015.05.059] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
26 Kang WH, Hwang S, Song GW, Jung DH, Kim KH, Park GC, Ha TY, Ahn CS, Moon DB, Yoon YI, Shin MH, Kim WJ, Kim SH, Lee SG. Donor Safety and Recipient Liver Function After Right-Lobe Liver Transplantation From Living Donors With Gilbert Syndrome. Transplant Proc 2015;47:2827-30. [PMID: 26707296 DOI: 10.1016/j.transproceed.2015.10.050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
27 Paro A, Tsilimigras DI, Dalmacy D, Mirdad RS, Hyer JM, Pawlik TM. Impact of Metabolic Syndrome on Postoperative Outcomes Among Medicare Beneficiaries Undergoing Hepatectomy. J Gastrointest Surg 2021. [PMID: 33547584 DOI: 10.1007/s11605-021-04926-1] [Reference Citation Analysis]
28 Seror M, Sartoris R, Hobeika C, Bouattour M, Paradis V, Rautou PE, Soubrane O, Vilgrain V, Cauchy F, Ronot M. Computed Tomography-Derived Liver Surface Nodularity and Sarcopenia as Prognostic Factors in Patients with Resectable Metabolic Syndrome-Related Hepatocellular Carcinoma. Ann Surg Oncol 2021;28:405-16. [PMID: 32965614 DOI: 10.1245/s10434-020-09143-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
29 Reddy SK, Hyder O, Marsh JW, Sotiropoulos GC, Paul A, Alexandrescu S, Marques H, Pulitano C, Barroso E, Aldrighetti L. Prevalence of nonalcoholic steatohepatitis among patients with resectable intrahepatic cholangiocarcinoma. J Gastrointest Surg. 2013;17:748-755. [PMID: 23355033 DOI: 10.1007/s11605-013-2149-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
30 Reddy SK, Reilly C, Zhan M, Mindikoglu AL, Jiang Y, Lane BF, Alexander HR, Culpepper WJ, El-Kamary SS. Long-term influence of chemotherapy on steatosis-associated advanced hepatic fibrosis. Med Oncol 2014;31:971. [PMID: 24798875 DOI: 10.1007/s12032-014-0971-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
31 Fischer A, Fuchs J, Stravodimos C, Hinz U, Billeter A, Büchler MW, Mehrabi A, Hoffmann K. Influence of diabetes on short-term outcome after major hepatectomy: an underestimated risk? BMC Surg 2020;20:305. [PMID: 33256698 DOI: 10.1186/s12893-020-00971-w] [Reference Citation Analysis]
32 Fahrner R, Patsenker E, de Gottardi A, Stickel F, Montani M, Stroka D, Candinas D, Beldi G. Elevated liver regeneration in response to pharmacological reduction of elevated portal venous pressure by terlipressin after partial hepatectomy. Transplantation. 2014;97:892-900. [PMID: 24621531 DOI: 10.1097/tp.0000000000000045] [Cited by in Crossref: 33] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
33 Nanashima A, Abo T, Arai J, Matsumoto H, Kudo T, Nagayasu T. Functional liver reserve parameters predictive for posthepatectomy complications. J Surg Res 2013;185:127-35. [PMID: 23746962 DOI: 10.1016/j.jss.2013.05.021] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
34 Starlinger P, Ubl DS, Hackl H, Starlinger J, Nagorney DM, Smoot RL, Habermann EB, Cleary SP. Combined APRI/ALBI score to predict mortality after hepatic resection. BJS Open 2021;5:zraa043. [PMID: 33609383 DOI: 10.1093/bjsopen/zraa043] [Reference Citation Analysis]
35 Nascimbeni F, Pais R, Bellentani S, Day CP, Ratziu V, Loria P, Lonardo A. From NAFLD in clinical practice to answers from guidelines. J Hepatol. 2013;59:859-871. [PMID: 23751754 DOI: 10.1016/j.jhep.2013.05.044] [Cited by in Crossref: 223] [Cited by in F6Publishing: 203] [Article Influence: 27.9] [Reference Citation Analysis]
36 Cauchy F, Fuks D, Zarzavadjian Le Bian A, Belghiti J, Costi R. Metabolic syndrome and non-alcoholic fatty liver disease in liver surgery: The new scourges? World J Hepatol 2014; 6(5): 306-314 [PMID: 24868324 DOI: 10.4254/wjh.v6.i5.306] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
37 Tashiro H, Kuroda S, Mikuriya Y, Ohdan H. Ischemia-reperfusion injury in patients with fatty liver and the clinical impact of steatotic liver on hepatic surgery. Surg Today. 2014;44:1611-1625. [PMID: 24078000 DOI: 10.1007/s00595-013-0736-9] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 6.8] [Reference Citation Analysis]
38 Khamphaya T, Chukijrungroat N, Saengsirisuwan V, Mitchell-Richards KA, Robert ME, Mennone A, Ananthanarayanan M, Nathanson MH, Weerachayaphorn J. Nonalcoholic fatty liver disease impairs expression of the type II inositol 1,4,5-trisphosphate receptor. Hepatology. 2018;67:560-574. [PMID: 29023819 DOI: 10.1002/hep.29588] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
39 Pawlik TM, Soubrane O. Metabolic syndrome-associated hepatocellular carcinoma: Questions still unanswered. J Hepatol 2015;63:8-9. [PMID: 25862602 DOI: 10.1016/j.jhep.2015.03.035] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
40 Garcia Caraballo SC, Comhair TM, Dejong CHC, Lamers WH, Koehler SE. Dietary treatment of fatty liver: High dietary protein content has an antisteatotic and antiobesogenic effect in mice. Biochim Biophys Acta Mol Basis Dis 2017;1863:1789-804. [PMID: 28457799 DOI: 10.1016/j.bbadis.2017.04.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
41 Tanoue Y, Nanashima A, Yano K, Fujii Y, Hiyoshi M, Imamura N, Hamada T, Ikenoue M, Wada T, Mizutani Y, Hirai T. Significance of the preoperative regional maximal removal rate of technetium-99m-galactosyl human serum albumin in the future remnant liver: a sequential study of regional maximal removal rate of technetium-99m-galactosyl human serum albumin in the whole liver. Nucl Med Commun 2019;40:145-52. [PMID: 30650068 DOI: 10.1097/MNM.0000000000000950] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
42 Uribe M, Uribe-Echevarría S, Mandiola C, Zapata MI, Riquelme F, Romanque P. Insight on ALPPS - Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy - mechanisms: activation of mTOR pathway. HPB (Oxford) 2018;20:729-38. [PMID: 29571618 DOI: 10.1016/j.hpb.2018.02.636] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
43 Mole DJ, Fallowfield JA, Kendall TJ, Welsh F, Semple SI, Bachtiar V, Kelly M, Wigmore SJ, James Garden O, Wilman HR, Banerjee R, Rees M, Brady M. Study protocol: HepaT1ca - an observational clinical cohort study to quantify liver health in surgical candidates for liver malignancies. BMC Cancer 2018;18:890. [PMID: 30208871 DOI: 10.1186/s12885-018-4737-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
44 Ricke J, Schinner R, Seidensticker M, Gasbarrini A, van Delden OM, Amthauer H, Peynircioglu B, Bargellini I, Iezzi R, De Toni EN, Malfertheiner P, Pech M, Sangro B. Liver function after combined selective internal radiation therapy or sorafenib monotherapy in advanced hepatocellular carcinoma. J Hepatol 2021:S0168-8278(21)02003-1. [PMID: 34454995 DOI: 10.1016/j.jhep.2021.07.037] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Geh D, Manas DM, Reeves HL. Hepatocellular carcinoma in non-alcoholic fatty liver disease-a review of an emerging challenge facing clinicians. Hepatobiliary Surg Nutr 2021;10:59-75. [PMID: 33575290 DOI: 10.21037/hbsn.2019.08.08] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
46 van Mierlo KM, Schaap FG, Dejong CH, Olde Damink SW. Liver resection for cancer: New developments in prediction, prevention and management of postresectional liver failure. J Hepatol. 2016;65:1217-1231. [PMID: 27312944 DOI: 10.1016/j.jhep.2016.06.006] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 8.4] [Reference Citation Analysis]
47 Tian Y, Li T, Qi S, Alhourani H, Luo B, Chenqin J, Fu Q, Peng Y, Wu J. The impact of metabolic syndrome (MetS) on surgical outcome for patients with mostly HBV-related hepatocellular carcinoma (HCC) underwent hepatectomy. J Surg Oncol 2020. [PMID: 32502302 DOI: 10.1002/jso.26055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Golubnitschaja O, Sridhar KC. Liver metastatic disease: new concepts and biomarker panels to improve individual outcomes. Clin Exp Metastasis 2016;33:743-55. [PMID: 27541751 DOI: 10.1007/s10585-016-9816-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 5.2] [Reference Citation Analysis]
49 Dokmak S, Ftériche FS, Borscheid R, Cauchy F, Farges O, Belghiti J. 2012 Liver resections in the 21st century: we are far from zero mortality. HPB (Oxford). 2013;15:908-915. [PMID: 23461811 DOI: 10.1111/hpb.12069] [Cited by in Crossref: 106] [Cited by in F6Publishing: 81] [Article Influence: 13.3] [Reference Citation Analysis]
50 Ray S, Mehta NN, Golhar A, Nundy S. Post hepatectomy liver failure - A comprehensive review of current concepts and controversies. Ann Med Surg (Lond). 2018;34:4-10. [PMID: 30181871 DOI: 10.1016/j.amsu.2018.08.012] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 9.7] [Reference Citation Analysis]
51 Sun Z, Yu Z, Yu S, Chen J, Wang J, Yang C, Jin M, Yan S, Zhang M, Zhang M, Zheng S. Post-Operative Complications in Living Liver Donors: A Single-Center Experience in China. PLoS One 2015;10:e0135557. [PMID: 26270475 DOI: 10.1371/journal.pone.0135557] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
52 Rahnemai-Azar AA, Cloyd JM, Weber SM, Dillhoff M, Schmidt C, Winslow ER, Pawlik TM. Update on Liver Failure Following Hepatic Resection: Strategies for Prediction and Avoidance of Post-operative Liver Insufficiency. J Clin Transl Hepatol. 2018;6:97-104. [PMID: 29577036 DOI: 10.14218/jcth.2017.00060] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 4.8] [Reference Citation Analysis]